Company Filing History:
1 out of 59 
1 out of 33 
1 out of 1 Years Active: 1982-2000
Title: The Innovative Contributions of Anna Bakonyi
Introduction
Anna Bakonyi is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the development of benzodiazepine derivatives. With a total of 3 patents, her work has implications for the treatment of various diseases affecting the central nervous system.
Latest Patents
Among her latest patents is the invention of new 1-[2-(substituted vinyl)]-3,4-dihydro-5H-2,3-benzodiazepine derivatives. This invention relates to a process for the preparation of these derivatives and pharmaceutical compositions that comprise them. The new compounds are designed to affect the central nervous system and can be utilized in therapeutic applications. Another significant patent involves 1-[2-(substituted vinyl)]-5H-2,3-benzodiazepine derivatives, which also includes a process for their preparation and their use in treating diseases. These compounds possess central nervous activities and are valuable in the pharmaceutical industry.
Career Highlights
Anna Bakonyi has worked with prominent companies in the pharmaceutical sector, including Egyt Gyógyszervegyészeti Gyár and Egis Gyógyszergyár Rt. Her experience in these organizations has contributed to her expertise in drug development and innovation.
Collaborations
Throughout her career, Anna has collaborated with notable professionals such as Pál Vágó and József Reiter. These partnerships have likely enhanced her research and development efforts in the pharmaceutical field.
Conclusion
Anna Bakonyi's innovative work in the development of benzodiazepine derivatives showcases her significant contributions to the pharmaceutical industry. Her patents reflect her commitment to advancing medical treatments and improving patient care.